2016 American Transplant Congress
Long Term Follow Up of Kidney Donors with Asymptomatic Renal Stones.
BACKGROUND:Kidney stones are often found incidentally in potential renal donors and there is a concern that they may become symptomatic and cause damage in the…2016 American Transplant Congress
Natural Language Processing Methods Allow Reliable Extraction of Banff Scores and Grades.
Objective: National Data are sparse with regard to pathology of rejection. Incorporating biopsy pathology grades and lesion scores into analyses requires manual extraction and entry…2016 American Transplant Congress
Evaluating Delayed Graft Function After Kidney Transplantation as a Potential Surrogate Outcome.
Department of Surgery, Johns Hopkins, Baltimore, MD.
Background: Recent work demonstrates significant inter-center heterogeneity in delayed graft function (DGF) rates after kidney transplantation, calling into question the value of a metric based…2016 American Transplant Congress
The Effect of Everolimus and Tacrolimus Exposure Levels on Renal Histology Parameters 6 Months Post-Transplantation.
We examined renal histology scores in patients with different exposure levels of everolimus (EVR) and tacrolimus (TAC) over 6 months.Renal transplant patients (N=613) were randomized…2016 American Transplant Congress
Incidence, Risk Factors, and Outcomes of Delayed Graft Function in Deceased Donor Kidney Transplantation in a Brazilian Center.
Background. A high incidence of delayed graft function (DGF), after deceased donor kidney transplantation, occurs in Brazil and the reasons for such finding have not…2016 American Transplant Congress
Comparison of Once-Daily and Twice-Daily Low-Dose Tacrolimus in Living Related Kidney Transplantation – Prospective Trial of Once-Daily vs. Twice-Daily Tac – 5 Years Second Report.
Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Background; Previously, we reported a comparison of the safety and pharmacokinetics between a prolonged-release formulation of Tacrolimus (Tac-QD) and twice-daily tacrolimus (Tac-BD) in the early…2016 American Transplant Congress
Impediments to Timely Listing for HIV+ Patients Being Evaluated for Kidney Transplantation.
Introduction:HIV+ individuals can be transplanted safely and effectively but face additional barriers in evaluation and listing.MethodsWe performed a single center chart review of all HIV+…2016 American Transplant Congress
A Weighted Approach to Composite Efficacy Analysis in Kidney Transplantation.
The US92 study determined whether, in de novo renal transplant patients, concentration-controlled everolimus (EVR) with reduced dose tacrolimus (RTAC) is non-inferior to CellCept® (mycophenolate mofetil…2016 American Transplant Congress
Validation of the Kidney Donor Risk Index (KDRI) in the Australian and New Zealand Kidney Transplant Population.
Purpose: The kidney donor risk index (KDRI), developed by the United States Scientific Registry of Transplant Recipients (SRTR), was designed to quantify donor kidney quality.…2016 American Transplant Congress
Soluble ST2 and Cardiovascular (CV) Outcomes and Mortality in Kidney Transplant Candidates.
1Mayo Clinic, Phoenix, AZ; 2Mayo Clinic, Rochester, MN.
Introduction: Soluble ST2(sST2), involved in T-cell mediated inflammation and cardiac fibrosis, is a better predictor of cardiovascular events(CVE) in heart failure(HF) and is less affected…
- « Previous Page
- 1
- …
- 416
- 417
- 418
- 419
- 420
- …
- 531
- Next Page »